TCB008
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TCB008, covering 2024-06-17 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML) [Phase 2]